Direct emissions
2,425
tCO2e
O
Oxford Biomedica (UK) Limited
Explore carbon emissions data for Oxford Biomedica (UK) Limited. Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.
This profile brings together available carbon emissions data for Oxford Biomedica (UK) Limited, including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. Read how we source and check this data.
Emissions
Carbon emissions
Total yearly emissions across all scopes
83,114 tCO2e (Market Based)
Scope 1
tCO2e
2,425
Scope 2 (Market Based)
tCO2e
1,337
Scope 3 total
tCO2e
79,351
Scope 3 reported
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Provenance
Emissions
Factors
492,672
kgCO2e / £M
Supplier specific emission factors (kgCO2e / £M)
Modelled
Reported
Scope 1 + 2
Direct + purchased energy
22,302
22,302
Upstream
+ upstream Scope 3
304,131
301,896
Total
+ all Scope 3
492,672
392,842
Which figure should I use?
Use Modelled. It is the most complete view: any categories the company hasn't disclosed are filled with industry-typical estimates, so a transparent company isn't unfairly penalised against one that simply hasn't reported.
Reported counts only emissions the company has filed itself. A blank or low Reported cell doesn't mean those emissions don't exist, just that the company hasn't disclosed them.
When Reported sits close to Modelled, that is a positive signal. The company has disclosed most of its salient emissions and there's little gap for the model to fill. Even then, Modelled is the right figure to use for a like-for-like comparison across companies.
Sustainability
Snapshot
Based on reported data, retrieved with AI
- Oxford Biomedica (UK) Limited reported 83,114 tCO₂e in 2025.
- Scope 3 accounted for 95% of emissions.
- Reported across 9 of 15 GHG Protocol Scope 3 categories.
- Scope 2 reported under the market based methodology.
According to available emissions disclosures, Oxford Biomedica (UK) Limited reported total yearly emissions of 83,114 tCO₂e in 2025. Scope 3 emissions accounted for 95% of reported output, indicating supply chain activity, purchased goods and services, business travel, and wider operational dependencies were the most significant contributors to the company's carbon footprint.
The company achieved a Mycelium Score of 1.3, placing it well below average for its sector for sustainability performance, and received a transparency score of 33.0, pointing to very little public detail on their key emissions.
Total Emissions across all scopes
83,114 tCO2e (Market Based)
Scope 1 emissions
Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.
Scope 2 emissions
Indirect emissions from purchased energy, including electricity, heating and cooling.
Location based
3,041
tCO2eMarket based
1,337
tCO2eScope 3 emissions
Wider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.
Cat 1
Purchased goods & services
42,967
tCO2eCat 2
Capital goods
189
tCO2eCat 3
Fuel & energy related activities
1,314
tCO2eCat 4
Upstream transportation & distribution
371
tCO2eCat 5
Waste generated in operations
50
tCO2eCat 6
Business travel
698
tCO2eCat 7
Employee commuting
1,768
tCO2eCat 8
Upstream leased assets
189
tCO2eCat 9
Downstream transportation & distribution
12,019
tCO2eCat 10
Processing of sold products
3,304
tCO2eCat 11
Use of sold products
11,814
tCO2eCat 12
End-of-life treatment of sold products
0
tCO2eCat 13
Downstream leased assets
189
tCO2eCat 14
Franchises
189
tCO2eCat 15
Investments
4,273
tCO2e6 values were derived via Mycelium's normalisation process rather than reported by the company. Cells marked “–” were not disclosed.
Contact Info
Website
www.oxfordbiomedica.co.ukAddress
Windrush Court
Transport Way
Oxford
Oxford
Oxfordshire
OX4 6LT
Country
United Kingdom
Phone
+44 1865 783000Browse carbon emissions data by industry
Jump straight into the sectors users explore most, or view all industries.
How scoring works
How the Mycelium Score is calculated
The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs sector peers (emissions normalised against revenue). The remaining 3.5 reflect data quality: third-party verified, profile claimed by the company, and full disclosure across all reporting categories.
A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. Oxford Biomedica (UK) Limited's score sits at the top of this page and in the score panel.
How the Transparency Score is calculated
The Transparency Score measures how much of a company's key emissions data is publicly disclosed, graded from A (very high) down to F (very low). Crucially, it weights each gap by how material that bucket is for the company's industry, so an undisclosed category where the bulk of emissions sit hurts far more than a minor one.
For Oxford Biomedica (UK) Limited, the single biggest gap is Use of sold products (Scope 3 Category 11). Mycelium estimates it accounts for around 14% of the company's total footprint, typically the largest source of emissions for a Services company, yet it hasn't been disclosed. Leaving a bucket this large unreported is what's holding the transparency score down.
Other material categories Oxford Biomedica (UK) Limited hasn't disclosed:
- Investments (Scope 3 Category 15), around 5% of the estimated footprint
In total, roughly 19% of Oxford Biomedica (UK) Limited's estimated emissions sit in categories it hasn't reported. Disclosing these would be the fastest way to raise the transparency score.
Read the full scoring methodology
Our white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.
Download the white paper (PDF)
Oxford Biomedica (UK) Limited carbon emissions FAQs
What are Oxford Biomedica (UK) Limited's carbon emissions?
In its 2025 reporting year, Oxford Biomedica (UK) Limited disclosed total emissions of 83,114 tCO2e across all scopes. Scope 3 accounted for the largest share, around 95% of the total.
Does Oxford Biomedica (UK) Limited report Scope 1, Scope 2 and Scope 3 emissions?
For 2025, Oxford Biomedica (UK) Limited's available disclosure covers Scope 1 (2,425 tCO2e), Scope 2 (1,337 tCO2e), Scope 3 across 9 of the 15 GHG Protocol categories. Figures not reported by the company are shown as modelled estimates and labelled as such.
How transparent is Oxford Biomedica (UK) Limited's emissions reporting?
Oxford Biomedica (UK) Limited has a Mycelium transparency score of 33 out of 100. The score weights each emissions category by how material it is for the company's industry, so it reflects whether the disclosures that matter most have been made.
Is Oxford Biomedica (UK) Limited sustainable?
Mycelium measures sustainability through carbon emissions data rather than giving a yes or no verdict. Oxford Biomedica (UK) Limited has a Mycelium Score of 1.3 out of 10, which reflects its emissions intensity against sector peers together with how transparent and well-verified its reporting is. The emissions figures, disclosure documents and climate targets on this page give the fuller picture.
Is Oxford Biomedica (UK) Limited environmentally friendly?
Carbon emissions are one measurable part of environmental impact, and the part Mycelium tracks. Oxford Biomedica (UK) Limited disclosed 83,114 tCO2e for 2025, and its Mycelium Score of 1.3 out of 10 shows how that performance compares with similar companies in its sector.
Learn more about our methodology and where this data comes from.
